In acute myeloid leukemia (AML), chemotherapeutic stress activates UPR transcription factors (e.g., XBP1 and ATF4), while lysosomal adaptation supports survival and ROS enhances genomic instability [99,143]. Here, ATF4 is linked to acute myeloid leukemia.